The “Veterinary Therapeutics Market Size” is projected to grow at a significant rate on account of rising demand for meat and meat products. Fortune Business Insights in its new report, titled “Veterinary Therapeutics Market Size, Share and Global Trend by Product Type (Drugs, Vaccines), Animal Type (Companion, Livestock), Route of Administration (Oral, Parenteral, Topical), Distribution Channels (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) and Geography Forecast till 2025” finds that the growing population across the world is positively impacting the veterinary therapeutics market.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/veterinary-therapeutics-market-100138
Detailed Table of Content:
1.Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2.Executive Summary
3.Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.Key Insights
4.1 Pipeline Analysis
4.2 Regulatory Scenario for Key Countries
4.3 Pricing Analysis
4.4 Key Industry Developments
4.5 Overview of Animal Diseases by Key Countries
4.6 Snapshot on the Novel & Upcoming Therapies
4.7 Overview of Treatment Plans for Different Animal Diseases
4.8 Overview of Incidence & Prevalence of Animal Diseases
Continued...
Market Segmentation:
By Product Type
- Drugs
- Vaccines
- Medicated Feed Additives
By Animal Type
- Companion
- Livestock
By Route of Administration
- Oral
- Parenteral
- Topical
By Distribution Channels
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Geography
- North America (USA and Canada)
- Europe (Germany, U.K., France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (China, India, Japan, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East & Africa (GCC Countries, South Africa, Rest of Middle East & Africa)
Veterinary Therapeutics Market: IntroductionAccording to the report, the global veterinary therapeutics market was valued at ~US$ 36 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.
Veterinary therapeutics is a branch of animal healthcare that deals with prevention, treatment, and alleviation of several diseases.
The veterinary therapeutics market consists of drugs for the treatment of animal diseases, vaccines for the prevention of various pathological conditions, and feed additives to maintain the overall well-being of animals by providing all the necessary nutrients required to lead a long, healthy life.
Growth of the global veterinary therapeutics market can be attributed to rise in spending on companion animals globally and demand for high quality protein.
The others sub-segment includes specialty pharmaceuticals used to treat conditions such as cardiovascular, metabolic, and respiratory disorders.Livestock Animal to Offer Lucrative OpportunitiesIn terms of animal, the global veterinary therapeutics market has been classified into companion animal and livestock animal.
The livestock animal segment is expected to dominate the market during the forecast period, due to increase in demand for livestock products globally, which leads to surge in expenditure on livestock therapeutic care.
In addition, it also delivers detailed analysis of regional and country market.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the veterinary therapeutics market include Zoetis, Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim GmbH, Ceva Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Biovac, The Chanelle Group, ImmuCell Corporation.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Veterinary Therapeutics Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/veterinary-therapeutics-market/download-sampleMarket DynamicsCommercialization and R activities of new products act as a key driver for the veterinary therapeutics market.
The substantial increase in the number of pet animals globally, growth and advancement in surgical and medical capabilities related to the animal treatment, rising focus on enhancing the overall wellness of animals, and significant progress in the development of new vaccines and medicines to curb the occurrence of new diseases are significant factors foreseen to influence the progress of the veterinary therapeutics market.
However, evolving regulatory framework and trade, travel and market restrictions due to novel coronavirus pose serious challenges for the market participants.
The market participants are anticipated to focus on the expansion of their product portfolio and surge investments in the development of DNA vaccines.
